DRTS (Alpha Tau Medical) ROE % Adjusted to Book Value : -16.09% (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Alpha Tau Medical ROE % Adjusted to Book Value?

Alpha Tau Medical's ROE % for the quarter that ended in Sep. 2024 was -38.62%. Alpha Tau Medical's PB Ratio for the quarter that ended in Sep. 2024 was 2.40. Alpha Tau Medical's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -16.09%.

Alpha Tau Medical ROE % Adjusted to Book Value Historical Data

The historical data trend for Alpha Tau Medical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Tau Medical ROE % Adjusted to Book Value Chart

Alpha Tau Medical Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

-45.80

-12.37

Alpha Tau Medical Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial													-7.35	-13.63	-15.02	-16.11	-16.09

Competitive Comparison of Alpha Tau Medical's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Alpha Tau Medical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alpha Tau Medical's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Tau Medical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Alpha Tau Medical's ROE % Adjusted to Book Value falls into.

Alpha Tau Medical ROE % Adjusted to Book Value Calculation

Alpha Tau Medical's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-30.67%	/	2.48
	=	-12.37%

Alpha Tau Medical's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-38.62%	/	2.40
	=	-16.09%

Alpha Tau Medical ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Alpha Tau Medical's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Alpha Tau Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Tau Medical Ltd (NAS:DRTS) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kiryat Hamada Street 5, Building B3, 4th Floor, Jerusalem, ISR, 9777605

Website

https://www.alphatau.com

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.